Taizong Wu

Dr. Taizong Wu is a researcher at the Institute for Molecular Bioscience (IMB), University of Queensland, specializing in natural product chemistry and microbial biodiscovery. His work focuses on isolating and characterizing bioactive compounds from marine and terrestrial microorganisms, particularly fungi and actinomycetes, to identify novel pharmaceutical candidates for combating antimicrobial resistance and osteoporosis.

He has contributed to the discovery of diverse metabolites, including steroidal lactones from deep-sea fungi, glyclauxin aminoglycosides from wasp nest-derived Talaromyces, and polycyclic anti-osteoporosis agents from Rhizopus species. His research integrates molecular networking analysis with cultivation strategies to unravel microbial biodiversity and natural product biosynthesis pathways.

Key areas of focus include understanding the structural diversity of polyketides, enamine-pyranonaphthoquinones, and C-deoxyaminoglycosides, along with their potential applications in drug development. Wu collaborates extensively on projects involving Australian-derived microbes from environments such as soil, pasture plants, and fish guts, emphasizing the exploration of underutilized microbial resources for biomedical innovation.

His publications highlight advancements in isolating bioactive compounds with antibacterial, antiosteoporotic, and antioxidant properties, often employing cutting-edge techniques like LC-MS-based molecular networking and structural elucidation.